BlackRock’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190M Buy
15,939,953
+247,939
+2% +$2.54M ﹤0.01% 1705
2025
Q4
$156M Buy
15,692,014
+441,070
+3% +$4.21M ﹤0.01% 1845
2025
Q3
$136M Buy
15,250,944
+132,706
+0.9% +$1.23M ﹤0.01% 1908
2025
Q2
$143M Sell
15,118,238
-801,812
-5% -$7.07M ﹤0.01% 1822
2025
Q1
$173M Sell
15,920,050
-536,060
-3% -$5.39M ﹤0.01% 1682
2024
Q4
$157M Buy
16,456,110
+267,323
+2% +$2.71M ﹤0.01% 1803
2024
Q3
$182M Buy
16,188,787
+2,613,303
+19% +$27.8M ﹤0.01% 1716
2024
Q2
$136M Sell
13,575,484
-69,170
-0.5% -$703K ﹤0.01% 1851
2024
Q1
$157M Sell
13,644,654
-421,911
-3% -$3.58M ﹤0.01% 1799
2023
Q4
$103M Buy
14,066,565
+924,068
+7% +$7.29M ﹤0.01% 2060
2023
Q3
$120M Buy
13,142,497
+1,542,284
+13% +$18.5M ﹤0.01% 1888
2023
Q2
$141M Sell
11,600,213
-275,325
-2% -$3.07M ﹤0.01% 1819
2023
Q1
$148M Buy
11,875,538
+3,388
+0% +$62.3K ﹤0.01% 1775
2022
Q4
$228M Sell
11,872,150
-49,857
-0.4% -$1.05M 0.01% 1429
2022
Q3
$224M Buy
11,922,007
+6,568,394
+123% +$135M 0.01% 1387
2022
Q2
$96.6M Buy
5,353,613
+71,189
+1% +$1.16M ﹤0.01% 2026
2022
Q1
$84.7M Sell
5,282,424
-13,652
-0.3% -$245K ﹤0.01% 2238
2021
Q4
$130M Buy
5,296,076
+34,062
+0.6% +$800K ﹤0.01% 2035
2021
Q3
$123M Sell
5,262,014
-326,033
-6% -$7.88M ﹤0.01% 2087
2021
Q2
$153M Buy
5,588,047
+566,410
+11% +$16.2M ﹤0.01% 1970
2021
Q1
$185M Buy
5,021,637
+3,049,727
+155% +$108M 0.01% 1785
2020
Q4
$74.1M Buy
1,971,910
+511,637
+35% +$15.8M ﹤0.01% 2249
2020
Q3
$31.8M Buy
1,460,273
+1,090,557
+295% +$22.9M ﹤0.01% 2575
2020
Q2
$5.95M Buy
369,716
+363,262
+5,628% +$6.07M ﹤0.01% 3454
2020
Q1
$103K Buy
+6,454
New +$91.2K ﹤0.01% 4346

Other funds holding AHCO

BlackRock's AHCO Position: Q1 2026 in Review

BlackRock increased its AdaptHealth (AHCO) stake by 1.6% in Q1 2026, buying an estimated $2.54M and bringing the position to 15,939,953 shares worth $190M. The position accounts for ﹤0.01% of the portfolio, ranked #1705.

BlackRock first reported a position in AHCO in Q1 2020 and has held it in 25 quarters since. The position peaked at $228M in Q4 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • BlackRock held 15,939,953 shares of AdaptHealth worth $190M as of Q1 2026.
  • BlackRock bought 247,939 AdaptHealth shares in Q1 2026, an estimated $2.54M.
  • AdaptHealth made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #1705 holding.
  • BlackRock first reported a position in AdaptHealth in Q1 2020 and has held it in 25 quarters since.
  • BlackRock's AdaptHealth position peaked at $228M in Q4 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.